LAMA2 and muscular dystrophy: We demonstrate that these peptides ameliorate the in vitro phenotype of myoblasts from mice with LAMA2-related muscular dystrophy and show that they can be chemically modified for bioconjugation, in vivo delivery to the basal-lamina, and as probes to visualize their target ECM receptors in myoblasts and MuSCs.